<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Buprenorphine/<z:chebi fb="1" ids="7459">naloxone</z:chebi> is used for the treatment of <z:e sem="disease" ids="C0524662" disease_type="Mental or Behavioral Dysfunction" abbrv="">opioid dependence</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In the following case, a potential use for the medication combination is explored in the arena of transplant surgery </plain></SENT>
<SENT sid="2" pm="."><plain>Psychiatry was consulted for a 29-year-old woman with iatrogenic <z:e sem="disease" ids="C0524662" disease_type="Mental or Behavioral Dysfunction" abbrv="">opioid dependence</z:e> after bilateral ventricular assist device placement for congenital <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Her ejection fraction was less than 15% and she was considered a poor candidate for transplant due to drug-seeking behaviors </plain></SENT>
<SENT sid="4" pm="."><plain>We transitioned her onto buprenorphine/<z:chebi fb="1" ids="7459">naloxone</z:chebi> to prevent abuse and control symptoms, qualifying her for cardiac transplant </plain></SENT>
<SENT sid="5" pm="."><plain>After transplant, we coordinated care with cardiothoracic surgeons to restart buprenorphine/<z:chebi fb="1" ids="7459">naloxone</z:chebi>, and the patient has been stable for 8 months </plain></SENT>
</text></document>